← FDA DRUG APPROVALS

FDA NDA · NDA014122

PROTOPAM CHLORIDE

Sponsor: WYETH AYERST

APPLICATION
NDA014122
TYPE
NDA
ORIGINAL APPROVAL
1964-03-12
LATEST ACTION
1987-08-24
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PROTOPAM CHLORIDEDiscontinued
PRALIDOXIME CHLORIDE 500MG · TABLET · ORAL

Approval history

1987-08-24Manufacturing (CMC) · Supplement 16 · priorityAP
1985-08-21Manufacturing (CMC) · Supplement 15 · priorityAP
1985-07-03Labeling · Supplement 14 · priorityAP
1985-05-20Manufacturing (CMC) · Supplement 13 · priorityAP
1981-06-16Manufacturing (CMC) · Supplement 12 · priorityAP
1979-10-01Manufacturing (CMC) · Supplement 10 · priorityAP
1979-10-01Manufacturing (CMC) · Supplement 11 · priorityAP
1974-11-11Supplement · Supplement 9 · priorityAP
1974-11-08Manufacturing (CMC) · Supplement 5 · priorityAP
1974-06-27Supplement · Supplement 8 · priorityAP
1964-03-12Type 3 - New Dosage Form · Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →